Immunome Research
Open Access
ISSN: 1745-7580
+44-20-4587-4809
ISSN: 1745-7580
+44-20-4587-4809
Cedrik M. Britten
Head
Cellular Therapy-Immuno-oncology
GlaxoSmithKline Deutschland
Germany
Dr. Cedrik M. Britten is the Head Cellular Therapy-Immuno-oncology at GlaxoSmithKline Deutschland (GSK), Germany. He completed his Doctor of Medicine (M.D.) from University Medical Center of the Johannes-Gutenberg University in the year 2001.
His research interest includes Immunology, Cell Culture, Molecular Biology and Cancer.